Access the full text.
Sign up today, get DeepDyve free for 14 days.
M Spatola, J Novy, R Pasquier, J Dalmau, AO Rossetti (2015)Status epilepticus of inflammatory etiology: a cohort study
Ines Kanter, H. Huttner, D. Staykov, T. Biermann, T. Struffert, F. Kerling, M. Hilz, P. Schellinger, S. Schwab, J. Bardutzky (2008)Cyclophosphamide for anti‐GAD antibody‐positive refractory status epilepticus
H. Wieser (2004)Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis
V. Nociti, G. Frisullo, T. Tartaglione, A. Patanella, R. Iorio, P. Tonali, A. Batocchi (2010)Refractory generalized seizures and cerebellar ataxia associated with anti‐GAD antibodies responsive to immunosuppressive treatment
European Journal of Neurology, 17
A. Vincent, S. Irani, B. Lang (2010)The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins
Current Opinion in Neurology, 23
P. Niehusmann, J. Dalmau, C. Rudlowski, A. Vincent, C. Elger, J. Rossi, C. Bien (2009)Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy.
Archives of neurology, 66 4
B. Engelsen, M. Grønning (1997)Epileptic seizures in patients with multiple sclerosis. Is the prognosis of epilepsy underestimated?
Michael Hutchinson, P. Waters, J. McHugh, G. Gorman, S. O'Riordan, S. Connolly, H. Hager, P. Yu, C. Becker, A. Vincent (2008)PROGRESSIVE ENCEPHALOMYELITIS, RIGIDITY, AND MYOCLONUS: A NOVEL GLYCINE RECEPTOR ANTIBODY
M. Rogawski, W. Löscher (2004)The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions
Nature Medicine, 10
S. Irani, K. Bera, P. Waters, L. Zuliani, S. Maxwell, M. Zandi, M. Friese, I. Galea, D. Kullmann, D. Beeson, B. Lang, C. Bien, A. Vincent (2010)N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
M. Petit-Pedrol, T. Armangué, Xiaoyu Peng, L. Bataller, T. Cellucci, Rebecca Davis, Lindsey McCracken, E. Martinez-Hernandez, W. Mason, M. Kruer, David Ritacco, W. Grisold, B. Meaney, C. Alcalá, P. Sillevis-Smitt, M. Titulaer, R. Balice-Gordon, F. Graus, J. Dalmau (2014)Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies
The Lancet Neurology, 13
P. Kwan, G. Sills, K. Kelly, E. Butler, M. Brodie (2000)Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study
Epilepsy Research, 42
Meredith Spindler, L. Jacks, Xi Chen, K. Panageas, L. Deangelis, E. Avila (2013)Spectrum of Nonconvulsive Status Epilepticus in Patients With Cancer
Journal of Clinical Neurophysiology, 30
P Pettingill, HB Kramer, JA Coebergh, R Pettingill, S Maxwell, A Nibber, A Malaspina, A Jacob, SR Irani, C Buckley, D Beeson, B Lang, P Waters, A Vincent (2015)Antibodies to GABAA receptor alpha1 and gamma2 subunits: clinical and serologic characterization
F. Drislane (1994)Nonconvulsive status epilepticus in patients with cancer
Clinical Neurology and Neurosurgery, 96
J. Greenlee (2010)Faculty Opinions recommendation of Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia.
D. Chan, T. Thomas, M. Lim, S. Ling, M. Woodhall, A. Vincent (2017)Focal status epilepticus and progressive dyskinesia: A novel phenotype for glycine receptor antibody-mediated neurological disease in children.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 21 2
U. Cikrikcili, Canan Ulusoy, Selin Turan, S. Yildiz, B. Bilgiç, H. Hanagasi, B. Baykan, E. Tüzün, H. Gürvit (2013)Non-Convulsive Status Epilepticus Associated With Glutamic Acid Decarboxylase Antibody
Clinical EEG and Neuroscience, 44
E. Trinka, Hannah Cock, D. Hesdorffer, A. Rossetti, I. Scheffer, S. Shinnar, S. Shorvon, D. Lowenstein (2015)A definition and classification of status epilepticus – Report of the ILAE Task Force on Classification of Status Epilepticus
A. Quek, J. Britton, A. McKeon, E. So, V. Lennon, C. Shin, C. Klein, R. Watson, A. Kotsenas, T. Lagerlund, G. Cascino, G. Worrell, E. Wirrell, K. Nickels, A. Aksamit, K. Noe, S. Pittock (2012)Autoimmune epilepsy: clinical characteristics and response to immunotherapy.
Archives of neurology, 69 5
E. Tüzün, J. Dalmau (2007)Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment
The Neurologist, 13
L. Cocito, D. Audenino, A. Primavera (2001)Altered mental state and nonconvulsive status epilepticus in patients with cancer.
Archives of neurology, 58 8
H. Meierkord, P. Boon, B. Engelsen, B. Engelsen, K. Gocke, S. Shorvon, P. Tinuper, M. Holtkamp (2010)EFNS guideline on the management of status epilepticus in adults
European Journal of Neurology, 17
S. Liimatainen, M. Peltola, L. Sabater, M. Fallah, E. Kharazmi, A. Haapala, P. Dastidar, M. Knip, A. Saiz, J. Peltola (2010)Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy
N Gaspard, BP Foreman, V Alvarez, C Cabrera Kang, JC Probasco, AC Jongeling, E Meyers, A Espinera, KF Haas, SE Schmitt, EE Gerard, T Gofton, PW Kaplan, JW Lee, B Legros, JP Szaflarski, BM Westover, SM LaRoche, LJ Hirsch (2015)New-onset refractory status epilepticus: Etiology, clinical features, and outcome
P. Waters, M. Woodhall, K. O’Connor, M. Reindl, B. Lang, D. Sato, M. Juryńczyk, G. Tackley, J. Rocha, Toshiyuki Takahashi, T. Misu, I. Nakashima, Jacqueline Palace, K. Fujihara, M. Leite, A. Vincent (2015)MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
Neurology® Neuroimmunology & Neuroinflammation, 2
F. Holzer, A. Rossetti, A. Héritier-Barras, D. Zumsteg, R. Roebling, R. Huber, H. Lerche, I. Kiphuth, J. Bardutzky, C. Bien, M. Tröger, Gaby Schoch, H. Prüss, M. Seeck (2012)Antibody-Mediated Status Epilepticus: A Retrospective Multicenter Survey
European Neurology, 68
Philippa Pettingill, H. Kramer, J. Coebergh, Rosemary Pettingill, S. Maxwell, A. Nibber, A. Malaspina, A. Jacob, S. Irani, C. Buckley, D. Beeson, B. Lang, P. Waters, A. Vincent (2015)Antibodies to GABAA receptor α1 and γ2 subunits
P. Kaplan (2006)The EEG of Status Epilepticus
Journal of Clinical Neurophysiology, 23
F Graus, JY Delattre, JC Antoine, J Dalmau, B Giometto, W Grisold, J Honnorat, PS Smitt, C Vedeler, JJ Verschuuren, A Vincent, R Voltz (2004)Recommended diagnostic criteria for paraneoplastic neurological syndromes
J Neurol Neurosurg Psychiatry, 75
H. Durmuş, M. Kurtuncu, E. Tuzun, Münevver Pehlivan, G. Akman‐Demir, Z. Yapıcı, M. Eraksoy (2013)Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures
Acta Neurologica Belgica, 113
E. Ekizoğlu, E. Tuzun, M. Woodhall, B. Lang, L. Jacobson, S. Içoz, N. Bebek, C. Gurses, A. Gokyigit, P. Waters, A. Vincent, B. Baykan (2014)Investigation of neuronal autoantibodies in two different focal epilepsy syndromes
T. Brenner, G. Sills, Y. Hart, S. Howell, P. Waters, M. Brodie, A. Vincent, B. Lang (2013)Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy
D. Lowenstein, T. Bleck, R. Macdonald (1999)It's Time to Revise the Definition of Status Epilepticus
J. Palace, B. Lang (2000)Epilepsy: an autoimmune disease?
Journal of Neurology, Neurosurgery & Psychiatry, 69
H. Majoie, M. Baets, W. Renier, B. Lang, A. Vincent (2006)Antibodies to voltage-gated potassium and calcium channels in epilepsy
Epilepsy Research, 71
N. Gaspard, B. Foreman, V. Alvarez, Christian Kang, J. Probasco, Amy Jongeling, E. Meyers, Alyssa Espinera, K. Haas, Sarah Schmitt, Elizabeth Gerard, T. Gofton, P. Kaplan, Jong Lee, B. Legros, J. Szaflarski, B. Westover, S. Laroche, L. Hirsch (2015)New-onset refractory status epilepticus
R. Chin, B. Neville, R. Scott, R. Scott (2004)A systematic review of the epidemiology of status epilepticus
European Journal of Neurology, 11
HG Wieser (2004)ILAE, Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis
M. Spatola, M. Petit-Pedrol, M. Simabukuro, T. Armangué, Fernanda Castro, M. Artigues, M. Benique, L. Benson, M. Gorman, A. Felipe, Ruben Oblitas, M. Rosenfeld, F. Graus, J. Dalmau (2017)Investigations in GABAA receptor antibody-associated encephalitis
M. Spatola, J. Novy, R. Pasquier, J. Dalmau, A. Rossetti (2015)Status epilepticus of inflammatory etiology
A. Carvajal-González, M. Leite, P. Waters, M. Woodhall, E. Coutinho, B. Balint, B. Lang, Philippa Pettingill, A. Carr, U. Sheerin, R. Press, M. Lunn, M. Lim, P. Maddison, H. Meinck, W. Vandenberghe, A. Vincent (2014)Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes
John Thomas, T. Reagan, D. Klass (1977)Epilepsia partialis continua. A review of 32 cases.
Archives of neurology, 34 5
S. Shorvon (1994)Status Epilepticus: Its Clinical Features and Treatment in Children and Adults
K. McKnight, Yuwu Jiang, Y. Hart, A. Cavey, S. Wroe, M. Blank, Y. Shoenfeld, A. Vincent, Jacqueline Palace, B. Lang (2005)Serum antibodies in epilepsy and seizure-associated disorders
Jainn-Jim Lin, K. Lin, S. Hsia, Huei-Shyong Wang, I. Chou, Yun-Tong Lin (2012)Antiglutamic acid decarboxylase antibodies in children with encephalitis and status epilepticus.
Pediatric neurology, 47 4
Jehan Suleiman, Tanja Brenner, Deepak Gill, F. Brilot, Jayne Antony, Angela Vincent, Bethan Lang, Russell Dale (2011)VGKC antibodies in pediatric encephalitis presenting with status epilepticus
C. Poser, V. Brinar (2003)Epilepsy and multiple sclerosis
Epilepsy & Behavior, 4
SR Irani, S Alexander, P Waters, KA Kleopa, P Pettingill, L Zuliani, E Peles, C Buckley, B Lang, A Vincent (2010)Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan?s syndrome and acquired neuromyotonia
M. Atmaca, C. Gurses (2018)Status Epilepticus and Multiple Sclerosis: A Case Presentation and Literature Review
Clinical EEG and Neuroscience, 49
There have been recent reports of antibody-mediated status epilepticus. The objective of our study was to investigate the prevalence of neuronal autoantibodies in patients with status epilepticus (SE) with unresolved etiology. The presence of neuronal autoantibodies was investigated prospectively in adult patients with SE who presented to our clinic between February 2012 and December 2013 with unresolved etiology. Clinical and electrophysiologic features of seropositive patients were recorded. Also, seronegative and seropositive patient groups were compared in terms of demographic and clinical features, treatment responses, and outcomes. Neuronal antibodies against N-methyl-d-aspartate receptor (NMDA-R) were positive in 2 patients, against glycine receptor (Gly-R) in 2 patients, and against gamma-aminobutyric acid-A receptor [GABA(A)R] in 1 patient, which constituted a total of 5 (22.7%) of 22 patients with SE with unidentified etiology. One of three patients with systemic tumors was positive for GABA(A)R antibody. Four patients had a short epilepsy duration, while one of the NMDA-R antibody-positive patients had chronic epilepsy and double cortex finding in MRI. There was no significant difference between seropositive and seronegative patient groups in terms of demographic and clinical features, treatment responses, and outcomes. Neuronal antibodies are found in a sizeable portion of de novo SE patients, who are potential candidates of autoimmune encephalitis. Alternatively, these antibodies may presumably also emerge in SE patients with a chronic epilepsy history as an epiphenomenon. Further research is required to make the distinction between these two different antibody formation mechanisms.
Acta Neurologica Belgica – Springer Journals
Published: May 25, 2017
Access the full text.
Sign up today, get DeepDyve free for 14 days.